ABSTRACT. The objective of this study was to evaluate the estrogenic effects and mechanisms of three flavonoid components in Xiaoyao powder: quercetin, kaempferol, and isorhamnetin. The drugs were used to treat estrogen receptor (ER)-positive human breast cancer MCF-7 cells, and proliferation was measured using the MTT method. The expression of proteins and mRNA of the ER subtype were measured using western blotting and real time polymerase chain reaction. The quercetin (10 -2 µM, 10 -3 µM), kaempferol (100 µM, 10 -2 µM), and isorhamnetin (10 -3 µM) promoted the proliferation of MCF-7 cells, and the expression of ERα and ERβ proteins and mRNA were all increased significantly (P < 0.05). These effects were reversed by treatment with 0.1 µM estrogen antagonist ICI182780. Three flavonoid components in Xiaoyao powder increased the expression of proteins and mRNA of ERα and ERβ and promoted the proliferation of MCF-7 cells. These estrogenic effects were mediated by the ER.
INTRODUCTION
Climacteric syndrome is a series of clinical symptoms with an onset near menopause in females, in which premenopausal women show reproductive dysfunction of the hypothalamopituitary-ovary due to gradual decreasing of ovary function. The estrogen level of affected women is lower, and they exhibit menopausal symptoms such as nervous and neuropathy dysfunction, cardiovascular diseases, osteoporosis, and hectic fever. The symptoms have a major impact on women's physical and mental health (Lu et al., 2001; Wei, 2009) . Estrogen has been used to relieve the symptoms of menopause, but its effects on the uterus and breast are unclear and its clinical application is limited. Therefore, there is a need for an estrogen substitute without harmful side effects. Hence, the use of estrogen plants is being explored (Song and Wang, 2004) . Plant estrogens have a similar structure to estrogen and could combine with the estrogen receptor and exhibit estrogen effects. They could also play roles in climacteric syndrome, osteoporosis, and senile dementia (Tang et al., 2002; Moutsatsou, 2007) . The detection of active estrogen components from plant-based drugs is a popular research topic. These active components include flavonoids, isoflavones, coumarins, lignans, and triterpenesm, with most studies focusing on flavonoids. Xiaoyao powder is considered an effective treatment for climacteric syndrome and consists of bupleurum, angelica sinensis, poria cocos, atractylods, glycyrrhiza, white peony root, ginger, and mint. It can be used for soothing the liver, strengthening the spleen, and enriching blood and menstruation (Zhang and Lu, 2013) . In a study on the pharmacology of Xiaoyao powder used to treat normal and gonadectomy mice, Wang et al. (2003) reported that the Xiaoyao powder significantly increased the uterus weight of both control and gonadectomy mice (P < 0.01) and improved the estradiol level (P < 0.05), revealing that Xiaoyao powder has estrogen-mimicking effects (Wang et al., 2003) . Our previous studies using an ovariectomized mice model have also proven that Xiaoyao powder has estrogenic properties. In this study, we investigated the effects of three flavonoid components of Xiaoyao powder on the proliferation of MCF-7 cells, and protein and mRNA expression of ERα and ERβ. The changes were detected after the active plant estrogen was blocked by ICI182780. We have initially confirmed the effects of flavonoid components in Xiaoyao powder and provided an experimental reference for its use in the treatment of climacteric syndrome.
MATERIAL AND METHODS

Materials
Cell lines
The ER-positive human breast cancer cell line MCF-7 was supplied by a source center of Beijing, Xiehe.
Drugs
The purity of quercetin was 98% and the Chemical Abstract Service (CAS) number was ZL0083105. The purity of kaempferol was 98%, and its CAS number was ZL01290822. The purity of isorhamnetin was 98%, and its CAS number was ZL01900218. The chemicals were purchased from Nanjing Zelang. The estradiol purity was 98%, and the CAS number was L750N46. It was purchased from Bai Ling Wei. The estrogen antagonist ICI182780 purity was 99%, the CAS was 20A/129473, and it was obtained from Tocris Bioscience.
Reagents
Dulbecco's modified Eagle's medium (DMEM) high glucose, non-phenol red DMEM, charcoal/dextran-treated fetal bovine serum (CDT-FBS), and trypsase were purchased from the HyClone company. Dilmethly sulfoxide (DMSO) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma. The anti-human mice monoclone antibodies of ERα and ERβ were obtained from Santa Cruz, and the anti-mice goat IgG was purchased from Wuhan Boster. Trizol and the diethylpyrocarbonate water were purchased from Gibco. The PCR kit and primers were from Shanghai Sangon. 
Methods
Drug preparation
The estradiol (5.5 mg) was weighed and dissolved in 4 mL absolute ethyl alcohol. Then, 20 µM storage solution was prepared using non-phenol red DMEM. It was then diluted to 10 -6 µM. ICI182780 (1.0 mg) was weighed, and its storage solution was prepared with non-phenol red DMEM (200 µM). It was then diluted to 0.1 µM. Then, 3.0 mg quercetin, 5.8 mg kaempferol, and 6.4 mg isorhamnetin were weighed separately and dissolved in non-phenol red DMEM to make a 200 µM storage solutions. They were further diluted to make six different concentrations ranging from 10 -3 -100 µM.
Cell culture
Human breast cancer MCF-7 cells were cultured using DMEM with high glucose (including 10% FBS) and cultured at 37°C and 5% CO 2 . The cells were washed with phosphate buffered saline (PBS) 2-3 times per day 4 days before the experiment. Then, they were cultured with nonphenol red DMEM (containing 5% CDT-FBS).
MTT assay
MCF-7 cells were seeded on 96-well plates at a density of 6000 cells/well with non-phenol red DMEM for 4 days until reaching the logarithmic phase of growth. Then, 200 µL DMEM was added to each well and cells were treated with drugs after 24 h. The following groups were investigated: blank control group, positive control group (10 -6 µM estradiol), experimental drug groups (different concentrations of quercetin, kaempferol, and isorhamnetin), and each group consisted of 6 wells. MTT was added after treatment for 48 h and lysing the cells with DMSO. The absorption value of each well was measured at 490 nm using an ELISA microplate reader at an optical density (OD) of 490 nm, and then the average absorption value and proliferation rate (PR) were calculated. PR = experimental group / blank control group x 100%.
Antagonistic experiment
The cells were divided into a blank control group, positive control group (10 -6 µM estradiol), positive control +ICI182780 group, active plant estrogen group (10 -2 µM quercetin, 100 µM kaempferol, 10 -3 µM isorhamnetin), and active plant estrogen+ICI182780 group, with each group seeded in 6 wells. The cells were pretreated with 0.1 µM ICI182780 for 48 h. Then, MTT was added and the cells were lysed using DMSO. The absorption value of each well was measured at 490 nm using an ELISA microplate reader (OD 490), and then the average absorption value and PR were calculated.
Protein expression of ERα and ERβ in MCF-7 cells
MCF-7 cells were seeded on 10-cm culture dishes at a density of 1 x 10 6 cells/dish with non-phenol red DMEM and cultured for 4 days until reaching the logarithmic phase of cell growth. The drugs were changed after 24 h. Each group consisted of three dishes. They were divided into a blank control group, positive control group (10 -6 µM estradiol), positive control +ICI182780 group, active plant estrogen group (10 -2 µM quercetin, 100 µM kaempferol, 10 -3 µM isorhamnetin), and active plant estrogen+ICI182780 group. The cells were pretreated with 0.1 µM ICI182780 for 1 h. After 48 h, the cells were lysed using lysis buffer, and their protein was extracted. A 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate different proteins according to the target protein. The electrophoresis condition was 100 V for 90 min. The common wet transmembrane condition was 270 mA for 2 h. Then, the membrane was blocked with 5% non-fatty milk for 1 h. The antibodies of β-actin, ERα, and ERβ were diluted 1:300, and the membranes were incubated for 2 h at room temperature. Then, the secondary antibodies were diluted 1:3500, and the membranes were incubated for 1 h at room temperature. An electrochemiluminescence was used to develop the membrane. The Land ID gel-imaging system was used to analyze the results. The gray value rates of ERα/β-actin and ERβ/β-actin were calculated to show the protein expression level.
mRNA expression of ERα and ERβ in MCF-7 cells
The cells were seeded and cultured as previously described. After treating with drugs for 48 h, the total RNA in each group was extracted according to the manufacturer instructions using Trizol, and the Nano-100 micro-spectrophotometer was used to detect the A260 and A280 values. The RNA was acceptable when the A260/A280 value was in the range of 1.8-2.0, and then the total RNA was calculated. RNA (5 µg) was reverse transcribed to obtain cDNA using the following reaction conditions: 25°C 10 min, 42°C 60 min, and 70°C 10 min. β-actin was used as the reference gene, and the primer sequences are shown in Table 1 . The PCR amplification conditions were as follows: predenaturation at 94°C for 2 min; denaturation at 94°C for 30 s; annealing for 40 s (ERα 56.5°C, ERβ 54°C, and β-actin 56°C), and stretching at 72°C for 40 s for 35 cycles. The termination was performed at 72°C for 10 min. A 1.5% agarose gel was used to separate bands at 120 V for 30 min. The gel-pro gel analysis system was used to analyze the gel bands. ERK1/β-actin, ERK2/β-actin, and JNK2/β-actin were calculated. 
Statistical analysis
The SPSS 19.0 software was used to analyze the data, and the ANOVA, LSD, and SNK methods were used for comparisons among groups. All data are reported as means ± SD, and a P < 0.05 was considered statistically significant.
RESULTS
Effects on cell proliferation
The cell proliferation results are shown in Table 2 . Treatment with quercetin at concentrations of 100 µM (P < 0.05) and 10 µM (P < 0.05) significantly inhibited the proliferation of MCF-7 cells compared with the control group, which suggested that these concentrations were toxic to the cells and were not suitable for further experimentation. Treatment with 10 -2 and 10 -3 µM quercetin (P < 0.05), 100 and 10 -2 µM kaempferol (P < 0.01), and 10 -3 µM isorhamnetin significantly promoted cell proliferation. The effects were the same as treatment with estradiol, and the proliferation rates were in the range of 8-22%. Treatment with other concentrations of the drugs had no significant effects.
Effects of ICI182780 on the roles of three flavonoid components in promoting cell proliferation
The results are shown in Table 3 . Compared with the blank control group, the estradiol significantly promoted the proliferation of MCF-7 cells, with cells exhibiting a proliferation rate of 125% (P < 0.01). Quercetin, kaempferol, and isorhamnetin significantly promoted cell proliferation, with proliferation rates of 122, 128, and 121%, respectively (P < 0.01). Compared with the positive control group, ICI182780 reversed the proliferation effects of estradiol, with a rate of 113% (P < 0.05). Compared with the quercetin group, ICI182780 reversed the proliferation effects of quercetin, and the rate was 111% (P < 0.05). Compared with kaempferol, ICI182780 reversed the proliferation effects of kaempferol, and the rate was 119% (P < 0.05). Compared with isorhamnetin, ICI182780 reversed the proliferation effects of isorhamnetin, and the rate was 113% (P < 0.05).
Effects of three flavonoid components on the protein expression of ERα and ERβ in MCF-7 cells
The western blotting results are shown in Figure 1A Figure 1C, lane d) , and the differences were statistically significant (P < 0.01). Table 2 . Effects of three flavonoid components in Xiaoyao powder on cell proliferation (mean ± SD, N = 6).
Compared with blank control group, *P<0.05, **P<0.01. Table 3 . Effects of ICI182780 on the roles of three flavonoid components in promoting cell proliferation (mean ± SD, N = 6).
Compared with blank control group, *P < 0.05, **P < 0.01; compared with active plant estrogen group, # P < 0.05, ## P < 0.01.
Group
Concentration ( 
Effects of three flavonoid components on the mRNA expression of ERα and ERβ in MCF-7 cells
The results are shown in Table 4 and Figure Comparison with blank control group, *P < 0.05, **P < 0.01; comparison with active plant estrogen group, # P < 0.05, ## P < 0.01.
DISCUSSION
The E-screen selection method is a proliferation test for human breast cancer MCF-7 cells and is the classical evaluation method of estrogen activity in vitro. It can be used to detect estrogen effects and the strength of foreign estrogen. MCF-7 cells are human breast cancer cells with positive estrogen receptors, and estrogen or estrogen-like materials can combine with estrogen receptors to stimulate proliferation of MCF-7 cells. The experimental technique is simple, practical, and highly sensitivity. It is broadly applied for the fast selection and evaluation of plant estrogens (Payne et al., 2000) . Hence, MCF-7 cells were used to evaluate cell proliferation in this study. The cell proliferation rates determined by MTT suggested that certain doses of quercetin, kaempferol, and isorhamnetin can promote cell proliferation, and the effect was similar to that of estradiol. These results suggested that the three flavonoid components in Xiaoyao powder have estrogen-like effects.
Plant components play estrogen-like roles depending on the mediation of the ERs (Mueller, 2002) . ICI182780 is a kind of ER inhibitor and can decrease the effects of the signal transduction system that is mediated by a combination of estrogen and its receptors along with estrogenresponsive elements (Sommer et al., 2003) . In this study, to further confirm whether three flavonoids components in Xiaoyao powder promoted the proliferation of MCF-7 cells by acting on ERs, 0.1 µM ICI182780 was used to interfere with estradiol, quercetin, kaempferol, and isorhamnetin, and we found that their promoting effects were reversed by treatment with ICI182780. These results indicate that the proliferation-promoting effects of quercetin, kaempferol, and isorhamnetin might be mediated by ERs. ERs are members of the steroid receptors superfamily, and their transcription factors could combine with special DNA sequences to regulate gene expression (Tan and Wang, 2004) . ERs can be divided into two subtypes of different gene coding: ERα and ERβ (Rong and Jin, 2005) . Western blotting and RT-PCR were used in this study to measure the effects of quercetin, kaempferol, and isorhamnetin on the protein and mRNA expression of ERα and ERβ in MCF-7 cells. The results showed that isorhamnetin up-regulated the protein and mRNA expression of ERα and ERβ, and these effects could be reversed by treatment with ICI182780. Further studies are needed to confirm that the flavonoid components in Xiaoyao powder have estrogen-like effects via mediation of ERs and can stimulate the mRNA and protein of ERs in MCF-7 cells. This preliminarily study proved the estrogen-like effects and mechanism of three flavonoid components in Xiaoyao powder, providing a theoretical reference for its use in treating climacteric syndrome.
